Kieran. you, Thank
quarter of increase outlook for quarter an was of revenue the Total for year. $XX.X the year. rest our onto last the results first the million, Now QX first and X% of over
we we pleased with SINUVA. performance, our are hit yet stride with that While have we recognize to this
continue spend for access, of and the a both effort The SINUVA. SINUVA high by time ENT amount our access specialties. the consequence to market physicians drug for balance for market working of its on has degree growth with a both first significant of of physician-administered continue impact to and our kind ability required to We SINUVA sales team being PROPEL
which to do see discuss today. and further around you J assure preliminary me both decision I the seller Let on based that clerical code, success we our performance path of that SINUVA's will
However, experience months access the SINUVA's time elements historically to work for the in That the further well. that for and establish said, us, several SINUVA take role now through bandwidth April, issues for are our reflecting success. strong March to truly important we'll progressing long-term on we and expect foundation
mentioned, remains few deliver feedback who have treated approximately both of engaged prior attribute first a the revenue as patient the and than We per less through decline remains slight turnaround I quarter. continue We've through physician X to favorable. payer times coverage stable. broad QX and factors. clinical in authorization And addition over weeks and We SINUVA patients XXX in X,XXX
year, we to insurance deductibles. of impact did in fee the an resetting hypothesized we see the As earlier due from seasonality
bills. treated were to QX the overall process fell due access combined to hesitancy to getting short encouraged enrollments XX% physician on we QX, buying these in see Although, during a product inefficiencies engage over increase we with patients in
there While a as for authorization well is time offices. effort our team level and an of remains for amount resulting our time acceptable, for physician X-week prior as of in turnaround excessive higher back-and-forth
J reporting greater physician code new SINUVA smaller base a believe We without a wanted the allow SINUVA. SINUVA more J recent code incorporated that that space reflects into little CMS's decision bill to to information pleased we'd would assurance product I'm Additionally, hesitation. that combined allow front, for access our than to in the that will with see. provide XXX to of this them rose prescribe a we practices And [indiscernible] customer recognize buying and like have to our What of from preliminary on streamline assign on a more to for number their function to share on physicians this XXX.
to that will that This confidence which drug delivery new both a case micrograms. establish January intent decision a units to it to would streamline which and We process. of code carries SINUVA CMS micrograms typical of implant, be drug, eliminate X,XXX implant expect increase PROPEL. commonly XXX for they to expect such [XXXX,] communicated XXXX, a reimbursement. currently to X, described per assigned to code the of physicians straightforward this will submissions unit as payers we also preliminary around J the infusions structure coding submit code injection. indicated code the furoate so in as XX of is in be has CMS and and is physician mometasone of effective dose applied as
clarity from intent that see reported will there we J PROPEL CMS, believe to for under the we While code. new
into news. position physician SINUVA year, should in PROPEL J on be the place our the As the We Needless code access typically code, meeting welcome the separately to upcoming set J to [indiscernible] the to of facilities a code positive established. it even Net-net, say, reminder, may streamline overall. for XX-XX we reimbursed believe F next once not in J the payment surgical concurrence procedure. SINUVA is reinforce confidence CMS bolster is the help code as the to despite for and that do plan attend is will
evolve commercial have on to performing to challenges the At to a inefficient. a back we our year-to-date, us continuing to it step be are reflect strategy taking this access address is identified. that continues the So point, product clear to we process
on SINUVA, disproportionate amount sales is team PROPEL. selling diverting a spending Our away from attention
will we strive believe continue this We time. to to improve balance that resolve this with and
are of force field we SINUVA structure changes Specifically, the reimbursement doubled to the to have team the access. support implementing sales and size
team. force with greater SINUVA focus place through markets team SINUVA work a support approach to in Our will will additional benefit structure field on SINUVA sales in and our of We PROPEL. believe tandem sales this is immediately key that both specialists who a sales at
which Regarding have XX our beginning we team, individuals, from doubled the comprises up the year. XX the since second of now point, reimbursement nearly
educational through their funnels focused objectives: ensuring Our education SINUVA on both team they physicians an on helping two, office clinical treated; X to that and get access. patients that reimbursement for educate on both the out To the that we field physicians them staff. their class, April, product staff and is our end, rolled aspects and in and reimbursement for One, program primarily master
team We these the increased our move clear responsibilities hopeful to and needle forward the and attention sales believe required drive time have these are resources, in necessary We franchise. to help focused will also PROPEL roles growth our core customer allow us SINUVA. actions will and on education
needs PROPEL. deploying that of force team we as to With it not the we that fast meet SINUVA can growth these the rather is of are as important but rollout changes, so continued members strategically well expanding the our sales note
have across as a brought use and our rep. about X,XXX on treat which ENTs wraps, product patient on transitional [XX] which at fields of to brought that that our is fully measure We discontinued the XXX are staffed We contract believe size right engage presently with are were -- portfolio. target population
we to me our to outlook. learnings commercial X% X%. growth on let are Now and $XXX to on outlook turn XXXX revising of million Based million our $XXX to to our modifications strategy, continued
sinusitis. to conviction chronic the we SINUVA, the this for We in why through different our the our simple? expect is continuing with The how patient make it lives. making convention transitionary potential challenges growth in period. care It's to deliver SINUVA testimonials second work as of the behind standard the transforming quarter about flow want of modest of Despite I SINUVA reiterate is of in
patients come having the miserable can short how period time years. continue they a a who We to about time from breathe for utterly And being go hear in in to newly of life. freely first
patients, works, these life-changing a SINUVA For is difference. making it
able is favorite York, his now we is current this recently of have creating [indiscernible] patient focus team, focused chef to SINUVA. of accounts. is ensuring have life not expanding but encouraging anecdote access to been SINUVA. smell the to who PROPEL, a and the rollout meals from the can also physicians feedback believe This product to that best physician, at our selectively. my that expansion customers. physician continued and positive of addition continue from again. grow sufficient intently through is to our physicians, that team treated only sales we've new we uses accounting respect our his he and New highly accounts, With on who new amongst to he Historically, both we regarded PROPEL Contour usage why to with are feels with of This opportunity One use grow through is patients the
me let recent rates the to financial with commercial turn that growth results call will higher in Jeryl realignment. As take our of On to through that and actions resources, realign note, comes the to PROPEL outlooks. a you achieve these transition of result further now we believe after we initial the to over salesforce aspects
